---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-110269"
form_type: "8-K"
ticker: "HIT"
cik: "0002019505"
company_name: "Health In Tech, Inc."
filed_at: "2026-10-16T20:30:14+00:00"
generated_at: "2026-10-16T20:31:03.687765+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.62
calibrated_materiality_score: 0.62
confidence: "high"
source: SEC EDGAR
---

# Health In Tech gets two Nasdaq deficiency letters: audit committee makeup and sub-$1 bid price

## Summary
- Oct 14, 2026 Nasdaq letter: Board is 2-of-4 independent and Audit Committee has only 2 members after Sanjay Shrestha resigned Aug 10, 2026.
- Breaches Nasdaq Rules 5605(b)(1) and 5605(c)(2)(A); cure period runs to the earlier of the next annual meeting or Aug 10, 2027.
- Annual meeting set for Nov 10, 2026, where Health In Tech expects to elect a new independent director and add them to the Audit Committee.
- Oct 12, 2026 letter: Class A stock (HIT) closed below $1.00 for 30 straight business days, violating Rule 5550(a)(2); 180-day cure ends April 12, 2027.
- Regaining the bid price requires 10 consecutive closes at $1.00+; company may use a reverse stock split, and a second 180-day period is possible.

## SEC filing metadata
- accession: 0001213900-26-110269
- form_type: 8-K
- ticker: HIT
- cik: 0002019505
- company_name: Health In Tech, Inc.
- filed_at: 2026-10-16T20:30:14+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.62
- calibrated_materiality_score: 0.62
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2019505/000121390026110269/0001213900-26-110269-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2019505/000121390026110269/ea0308864-8k_health.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-110269
- JSON: https://secwatch.observer/filing/0001213900-26-110269.json
- Plain text: https://secwatch.observer/filing/0001213900-26-110269.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.